CAS: 1598383-40-4
Benzamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-[ethyl[trans-4-[(2-methoxyethyl)methylamino]cyclohexyl]amino]-2-methyl-5-[3-(4-morpholinyl)-1-propyn-1-yl]-
CAS:1598383-40-4
Formula:
C35H51N5O4
Purity:
%
Color and Shape:
Solid
Molecular weight:
605.8105
Ref: IN-DA001RF8
50mg | 159.00 € | ||
100mg | 269.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
EPZ011989
CAS:1598383-40-4
EPZ011989: potent, selective oral EZH2 inhibitor, Ki < 3 nM, 15x more selective than EZH1, >3000x over other HMTases.
Formula:
C35H51N5O4
Purity:
98% - 99.81%
Color and Shape:
Solid
Molecular weight:
605.81
Ref: TM-T2435
2mg | 41.00 € | ||
5mg | 57.00 € | ||
10mg | 83.00 € | ||
25mg | 129.00 € | ||
50mg | 200.00 € | ||
100mg | 359.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-[ethyl[trans-4-[(2-methoxyethyl)methylamino]cyclohexyl]amino]-2-methyl-5-[3-(4-morpholinyl)-1-propyn-1-yl]-benzamide-d8
Controlled ProductCAS:1598383-40-4
Formula:
C35D8H43N5O4
Color and Shape:
Neat
Molecular weight:
613.86
Ref: TR-D450172
25mg | 20,214.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
EPZ 011989
CAS:1598383-40-4
Inhibitor of lysine methyltransferase EZH2; antineoplastic
Formula:
C35H51N5O4
Purity:
Min. 95%
Molecular weight:
605.81 g/mol
Ref: 3D-FE137669
10mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025